150 related articles for article (PubMed ID: 28744327)
21. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
22. Regulation of mitochondrial morphology and cell cycle by microRNA-214 targeting Mitofusin2.
Bucha S; Mukhopadhyay D; Bhattacharyya NP
Biochem Biophys Res Commun; 2015 Oct; 465(4):797-802. PubMed ID: 26307536
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
24. PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington's Disease.
Cardinale A; Paldino E; Giampà C; Bernardi G; Fusco FR
PLoS One; 2015; 10(8):e0134482. PubMed ID: 26252217
[TBL] [Abstract][Full Text] [Related]
25. Aryl hydrocarbon receptor-dependent regulation of miR-196a expression controls lung fibroblast apoptosis but not proliferation.
Hecht E; Zago M; Sarill M; Rico de Souza A; Gomez A; Matthews J; Hamid Q; Eidelman DH; Baglole CJ
Toxicol Appl Pharmacol; 2014 Nov; 280(3):511-25. PubMed ID: 25178717
[TBL] [Abstract][Full Text] [Related]
26. miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts.
Kashiyama K; Mitsutake N; Matsuse M; Ogi T; Saenko VA; Ujifuku K; Utani A; Hirano A; Yamashita S
J Invest Dermatol; 2012 Jun; 132(6):1597-604. PubMed ID: 22358059
[TBL] [Abstract][Full Text] [Related]
27. PINK1-induced mitophagy promotes neuroprotection in Huntington's disease.
Khalil B; El Fissi N; Aouane A; Cabirol-Pol MJ; Rival T; Liévens JC
Cell Death Dis; 2015 Jan; 6(1):e1617. PubMed ID: 25611391
[TBL] [Abstract][Full Text] [Related]
28. Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
Díez-Planelles C; Sánchez-Lozano P; Crespo MC; Gil-Zamorano J; Ribacoba R; González N; Suárez E; Martínez-Descals A; Martínez-Camblor P; Álvarez V; Martín-Hernández R; Huerta-Ruíz I; González-García I; Cosgaya JM; Visioli F; Dávalos A; Iglesias-Gutiérrez E; Tomás-Zapico C
Pharmacol Res; 2016 Jun; 108():102-110. PubMed ID: 27155059
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
Ban JJ; Chung JY; Lee M; Im W; Kim M
Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
[TBL] [Abstract][Full Text] [Related]
30. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
[TBL] [Abstract][Full Text] [Related]
31. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
Hsiao HY; Chen YC; Chen HM; Tu PH; Chern Y
Hum Mol Genet; 2013 May; 22(9):1826-42. PubMed ID: 23372043
[TBL] [Abstract][Full Text] [Related]
32. Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.
Lu Z; Marks E; Chen J; Moline J; Barrows L; Raisbeck M; Volitakis I; Cherny RA; Chopra V; Bush AI; Hersch S; Fox JH
Neurobiol Dis; 2014 Nov; 71():34-42. PubMed ID: 25014023
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
Nithianantharajah J; Hannan AJ
Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
[TBL] [Abstract][Full Text] [Related]
35. Expression Profiles and Biological Roles of miR-196a in Swine.
Ning X; Liu S; Qiu Y; Li G; Li Y; Li M; Yang G
Genes (Basel); 2016 Jan; 7(2):. PubMed ID: 26805888
[TBL] [Abstract][Full Text] [Related]
36. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue.
Kim YJ; Bae SW; Yu SS; Bae YC; Jung JS
J Bone Miner Res; 2009 May; 24(5):816-25. PubMed ID: 19063684
[TBL] [Abstract][Full Text] [Related]
37. miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells.
Zhang J; Zheng F; Yu G; Yin Y; Lu Q
Biochem Biophys Res Commun; 2013 Nov; 440(4):582-8. PubMed ID: 24120501
[TBL] [Abstract][Full Text] [Related]
38. Altered microRNA expression in animal models of Huntington's disease and potential therapeutic strategies.
Martinez B; Peplow PV
Neural Regen Res; 2021 Nov; 16(11):2159-2169. PubMed ID: 33818488
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-196a/b Mitigate Renal Fibrosis by Targeting TGF-β Receptor 2.
Meng J; Li L; Zhao Y; Zhou Z; Zhang M; Li D; Zhang CY; Zen K; Liu Z
J Am Soc Nephrol; 2016 Oct; 27(10):3006-3021. PubMed ID: 26940097
[TBL] [Abstract][Full Text] [Related]
40. Study of plasma-derived miRNAs mimic differences in Huntington's disease brain.
Hoss AG; Lagomarsino VN; Frank S; Hadzi TC; Myers RH; Latourelle JC
Mov Disord; 2015 Dec; 30(14):1961-4. PubMed ID: 26573701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
